This federal contract award, with identification number SPE2DB22D1017|SPE2DB25FF0KY, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of 4,566,600 units of the pharmaceutical product Citalopram HBR 40 mg tablets, with a total ceiling value of $11,962.25. The contract type is a Delivery Order, with a Firm Fixed Price pricing structure, and an ultimate completion date of December 4, 2024.
Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999 IDC with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies to serve the healthcare needs of military personnel, veterans, and other federal beneficiaries.
The current contract award is not designated with any set-aside requirements, indicating open competition.
Generated 3/4/25, 11:12 AM